Spojené štáty - angličtina - NLM (National Library of Medicine)

kay chemical co. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - chloroxylenol 0.5 ml in 100 ml

Spojené štáty - angličtina - NLM (National Library of Medicine)

kay chemical co. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - chloroxylenol 5 mg in 1 ml - antiseptic handwash - for handwashing to decrease bacteria on the skin.

Spojené štáty - angličtina - NLM (National Library of Medicine)

kay chemical co. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antiseptic handwash - for handwashing to decrease bacteria on the skin

Spojené štáty - angličtina - NLM (National Library of Medicine)

kay chemical co. - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antiseptic handwash - for handwashing to decrease bacteria on the skin.

Japonsko - angličtina - すりの適正使用協議会 RAD-AR Council, Japan

tsumura & co. - keishibukuryogankayokuinin - light grayish white granules

Spojené štáty - angličtina - NLM (National Library of Medicine)

insmed incorporated - amikacin (unii: 84319sgc3c) (amikacin - unii:84319sgc3c) - limited population: arikayce® is indicated in adults, who have limited or no alternative treatment options, for the treatment of mycobacterium avium complex (mac) lung disease as part of a combination antibacterial drug regimen in patients who do not achieve negative sputum cultures after a minimum of 6 consecutive months of a multidrug background regimen therapy. as only limited clinical safety and effectiveness data for arikayce are currently available, reserve arikayce for use in adults who have limited or no alternative treatment options. this drug is indicated for use in a limited and specific population of patients. this indication is approved under accelerated approval based on achieving sputum culture conversion (defined as 3 consecutive negative monthly sputum cultures) by month 6. clinical benefit has not yet been established [see clinical studies (14)] . continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials. limitati

Európska únia - angličtina - EMA (European Medicines Agency)

insmed netherlands b.v. - amikacin sulfate - respiratory tract infections - antibacterials for systemic use, - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis.

Spojené štáty - angličtina - NLM (National Library of Medicine)

kay medic llc - menthol             3.00% - external analgesic for the temporary relief of minor aches, and pains of muscles and joints associated with simple backache, arthritis, strains, bruises and sprains. if symptoms persist for more than seven days, discontinue use and consult physician.

Izrael - angličtina - Ministry of Health

truemed ltd, israel - amikacin as sulfate - suspension for inhalation - amikacin as sulfate 70 mg/ml - amikacin - arikayce liposomal is indicated for the treatment of non-tuberculous mycobacterial (ntm) lung infections caused by mycobacterium avium complex (mac) in adults with limited treatment options who do not have cystic fibrosis. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Izrael - angličtina - Ministry of Health

sanofi israel ltd - polystyrene sulphonate sodium - powder for suspension - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.